Results 151 to 160 of about 13,456 (303)

Integrating Genetic Modifier Genotype With Serum Proteomics in Duchenne Muscular Dystrophy Clinical Trials Links LTBP4 Genetic Modifier to IL‐23/CD93 Pathways in Muscle

open access: yesAmerican Journal of Medical Genetics Part A, EarlyView.
ABSTRACT Genetic modifiers of Duchenne muscular dystrophy (DMD) that alter disease severity or response to therapy have been reported using natural history or registry data sets of older corticosteroid‐treated patients. We tested associations of genetic modifiers on motor function outcomes in young (4 to < 7 years) steroid naïve clinical trial ...
Utkarsh J. Dang   +16 more
wiley   +1 more source

Symbiotic novae [PDF]

open access: yes
(Invited Review) According to modern definition, a symbiotic nova is an otherwise normal nova (i.e. powered by explosive thermonuclear burning) that erupts within a symbiotic star, which is a binary where a WD accretes from a cool giant companion. Guided
Munari, Ulisse
core   +1 more source

Understanding Arthrogryposis Multiplex Congenita (AMC) Across the Lifespan: An Integrative Review of the Adult AMC Registry's Contributions With Lived Experience Partnerships

open access: yesAmerican Journal of Medical Genetics Part C: Seminars in Medical Genetics, EarlyView.
ABSTRACT This reflective essay explores how collaborative work between researchers and adults living with Arthrogryposis Multiplex Congenita (AMC) has deepened and broadened our understanding of what it means to live with this rare condition. By intentionally integrating the lived experiences of individuals with AMC into research processes, the ...
Bonita J. Sawatzky   +3 more
wiley   +1 more source

Temperature‐Controlled Radiofrequency for Severe Nasal Airway Obstruction: A Non‐Inferiority Comparison With Surgical Intervention

open access: yesInternational Forum of Allergy &Rhinology, EarlyView.
ABSTRACT Introduction Temperature‐controlled radiofrequency (TCRF), septoplasty (ST) with turbinate reduction, and functional rhinoplasty (FR) are treatment options for nasal airway obstruction (NAO) and nasal valve dysfunction (NVD), but no direct comparison of these procedures has been performed. Methods This prospective, open‐label, non‐inferiority (
Greg Davis   +13 more
wiley   +1 more source

Translation and Cross‐Cultural Adaptation of the Chronic Rhinosinusitis Control Test for Global Use

open access: yesInternational Forum of Allergy &Rhinology, EarlyView.
ABSTRACT Introduction The Chronic Rhinosinusitis Control Test (CRCT) is a patient‐reported outcome measure (PROM) written in English that is psychometrically validated to measure chronic rhinosinusitis control. Because the availability of translated PROMs is a driver of data equity—collection of data that is fair and generally representative—our ...
Hye K. Pae   +52 more
wiley   +1 more source

Advancements in CO2 Capture Technologies: A Review of Amine Absorption and Alternative Methods for Post‐Combustion Integration

open access: yesAsia-Pacific Journal of Chemical Engineering, EarlyView.
ABSTRACT Carbon capture technologies are poised to become one of the primary focuses regarding the achievement of net‐zero emissions by the year 2050. In these technologies, particular attention is given to post‐combustion CO2 capture, which is more easily implemented at existing power stations and other industries.
Satyajit Mukherjee   +3 more
wiley   +1 more source

De spermatozois observationes nonnullae novae

open access: yes
DE SPERMATOZOIS OBSERVATIONES NONNULLAE NOVAE Johannes Müller Library (-) De spermatozois observationes nonnullae novae (-
Bethe, Eduard
core   +1 more source

Design and Performance of a High‐Efficiency Inhibitor: Synergistic Effect of Modified Chitosan and Boron Nitride Nanosheets on Steel Protection

open access: yesAsia-Pacific Journal of Chemical Engineering, EarlyView.
ABSTRACT Metal corrosion causes significant economic losses and safety hazards, underscoring the urgent need for effective, environmentally friendly corrosion inhibitors. In this study, an organic–inorganic composite inhibitor, chitosan–glucose–BN (CS–GL–BN) was developed to protect Q235 mild steel in a 3.5‐wt% NaCl solution.
Shanjun Xu   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy